MENU
SION
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sionna Therapeutics (SION) Ownership - Who owns Sionna Therapeutics?

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.62B
P/E Ratio
N/A
Total Cash
216.15M
Projected Growth
N/A
Total Debt
8.38M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
SION
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details